Speech Language Therapy + Digital Storybook for Childhood Hearing Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if combining standard speech-language therapy with a digital storybook app called Hear Me Read can improve vocabulary, speech, and literacy in young children who are deaf or hard of hearing. The trial will compare outcomes between two groups: one receiving only traditional therapy and another using both the therapy and the digital app. Children who might be a good fit have hearing loss in both ears and are between the ages of 3 to just under 6 years old. This trial may be of interest to those whose child primarily uses English and has a form of hearing loss. As an unphased study, the trial offers a unique opportunity to explore innovative ways to enhance communication skills.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this digital storybook intervention is safe for children with hearing loss?
Research has shown that speech-language therapy is generally safe and well-received. It is a common treatment for children who are deaf or hard of hearing and has been used safely for many years.
Early results suggest that the Hear Me Read digital storybook is a safe addition to this therapy. Designed to complement speech-language therapy, the app aims to improve reading and language skills. No reports of problems have emerged from its use.
Both the standard therapy and the digital app are non-invasive, meaning they don't involve any procedures inside the body. Because of this, they are unlikely to cause harm. So far, using both the therapy and the app together seems promising in helping children improve their language skills without added risk.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it combines traditional speech language therapy with an innovative digital component, aiming to enhance language skills in children with hearing loss. Unlike the standard care, which involves regular sessions with a speech language pathologist, this approach incorporates the "Hear Me Read" app, allowing children to engage with interactive digital storybooks. This digital phase not only supplements traditional therapy but also provides an engaging way for children to practice reading, speech, and language skills at home, potentially accelerating their progress and making learning more enjoyable.
What evidence suggests that this trial's treatments could be effective for childhood hearing loss?
Research has shown that digital reading apps can help young children with normal hearing improve their language and reading skills. In this trial, some participants will receive standard speech-language therapy, while others will receive therapy combined with the digital storybook platform, Hear Me Read. Early results suggest that using Hear Me Read alongside speech-language therapy might help children who are deaf or hard of hearing enhance their vocabulary, speech, language, and reading skills. These interactive digital storybooks aim to make learning more enjoyable, potentially leading to better outcomes than therapy alone. This method builds on the past successes of digital reading tools in improving communication skills. Early signs are encouraging, indicating that the digital component could be a valuable tool in supporting these children's development.12356
Who Is on the Research Team?
Prasanth Pattisapu, MD
Principal Investigator
Nationwide Children's Hospital
Are You a Good Fit for This Trial?
This trial is for children aged 3 to nearly 6 with bilateral sensorineural or mixed hearing loss, including auditory neuropathy in both ears. It's not suitable for kids where English isn't the primary language or those who score more than 2 standard deviations from normal on a specific language test (CELF-P3).Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Period 1 (SLT)
Participants receive standard speech-language therapy as prescribed by their speech language pathologist. Reading time is prescribed at 20 minutes, 3 times a week, completed at home.
Intervention Period 2 (SLT+Digital)
Participants continue speech-language therapy with the addition of the Hear Me Read app. Reading time is prescribed at 20 minutes, 3 times a week, completed at home using the app.
Follow-up
Participants are monitored for safety and effectiveness after the intervention periods
What Are the Treatments Tested in This Trial?
Interventions
- Digital Software Application
- Speech Language Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Prashant Malhotra
Lead Sponsor
Prasanth Pattisapu
Lead Sponsor
Clinical and Translational Intramural Funding Program from the Abigail Wexner Research Institute
Collaborator